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Abstract
Introduction: The study was designed to clarify the role of 123I-β-methyl-
iodophenylpentadecanoic acid (123I-BMIPP) in the evaluation of myocardial fatty
acid metabolism in patients with stable angina pectoris (AP) before and after
percutaneous coronary intervention (PCI).
Material and methods: Ten controls (mean age: 70.4 ±10.5 years) and 12 patients
with AP (mean age: 67.4 ±11.6 years) and single vessel coronary artery disease
participated in the radionuclide cardiac study. Scintigraphic images were acquired
at 30 min and at 4 h after 123I-BMIPP injection to determine early and delayed
BMIPP uptake, respectively. The heart-to-mediastinum (H/M) ratio and 
the washout rate (WR) were calculated from the planar images. All patients
underwent scintigraphy one day before PCI and again 1 month after success  -
ful PCI.
Results: No significant differences in the early or delayed H/M ratios were
observed between the patients and the controls before PCI (early: 2.70 ±0.36
vs. 2.73 ±0.57; delayed: 2.26 ±0.33 vs. 2.40 ±0.43; p > 0.2 for both). The early
and delayed H/M ratios remained unchanged with the comparison with before
PCI (early: 2.72 ±0.27, delayed: 2.23 ±0.22; p > 0.2 for both). The global WR before
PCI was significantly higher in the patients than in the control group (36.7 ±9.3%,
vs. 28.1 ±8.2%, p = 0.02). However, the WR after PCI did not significantly differ
between the patients and the controls (34.3 ±7.8% vs. 28.1 ±8.2%, p = 0.1).
Conclusions: These data may suggest that the WR of 123I-BMIPP determined
from the planar images enhances the presence of myocardial ischaemia.
Key words: angina pectoris, β-methyl-iodophenylpentadecanoic acid, delayed image,
emission computed tomography.
Introduction
Myocardial fatty acid metabolism is widely assessed using radioiodine-
labelled 15-(p-iodophenyl)-3-(R,S)-methyl pentadecanoic acid (I-BMIPP) 
[1, 2]. The clinical use of I-BMIPP has been approved worldwide. Ischaemic
memory can be investigated by fatty acid imaging using single photon
emission computed tomography (SPECT) with radioiodine-labelled fatty
acid analogues such as I-BMIPP [3]. Fatty acid metabolism may be
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suppressed for a prolonged period after an
ischaemic episode and I-BMIPP imaging can
visualize regional metabolic defects [4]. Basic
kinetics and clinical implications have also been
extensively investigated using I-BMIPP [5-9]. Thus,
SPECT using I-BMIPP is clinically useful to diagnose
myocardial ischaemia and to assess the prognosis
of previous myocardial infarction [6] even in
patients with angina pectoris (AP) [7, 10]. A recent
study has identified I-BMIPP as a useful tracer for
defining regional ischaemic memory in patients
with exercise-induced myocardial ischaemia [3]. Our
previous study also suggested that 123I-β-methyl-
iodophenylpentadecanoic acid (123I-BMIPP) myocar  -
dial scintigraphy is a useful tool to predict masked
myocardial disease [8]. However, no studies have
fully investigated the effectiveness of radioisotopic
123I-BMIPP in the evaluation of myocardial fatty acid
metabolism in patients with stable AP after
percutaneous coronary intervention (PCI). The
present study aims to clarify the value of deter  -
mining fatty acid metabolism using 123I-BMIPP in
such patients before and after PCI.
Material and methods
Subjects
This study included 12 patients with AP (mean
age of 67.4 ±11.6 years) who underwent
myocardial 123I-BMIPP imaging and 10 healthy
controls (mean age of 70.0 ±9.5 years). Coronary
angiography confirmed AP in the 12 patients, all
of whom had single vessel coronary artery disease.
Of these, eight had AP in the left descending
coronary artery, and two each had AP in the left
circumflex and right coronary arteries respectively.
The mean score of disease severity was 2.1 ±0.7
according to the Canadian Cardiovascular Society
(CCS) classification [11]. None of the patients had
unstable AP, and all of them met the diagnostic
criteria for ischaemia in initial exercise stress
testing. None had a history of myocardial
infarction or coronary intervention. All patients
were prescribed with anti-platelet medication and
seven of them were also under statin therapy to
control dyslipidaemia. 
The healthy controls underwent symptom-
limited exercise stress testing to confirm that they
were free of ischaemic heart disease. All controls
achieved their target heart rates in sinus rhythm
without ischaemic ST-T changes or any complaints.
None of them had a history of cardiac disease or
any other extant medical conditions except
hyperlipidaemia. Cardiac function was assessed in
the controls by two-dimensional echocardiography
(SONOS-2500, Hewlett-Packard Co., MA, USA) to
exclude the possibility of having major heart
disease before the stress test.
Blood examination
Venous blood (5 ml) was collected from the
antecubital vein of each participant immediately
before the scintigraphic study to measure levels of
plasma brain natriuretic peptide (BNP). The blood
samples were immediately cooled on ice in
polypropylene tubes containing 4.5 mg of EDTA-2Na,
and then plasma samples separated by centri  -
fugation at 3,000 rpm for 10 min at 4°C were stored
frozen at –70°C. Plasma BNP concentrations were
measured using an immunoradiometric assay with
two monoclonal antibodies.
123I-BMIPP myocardial scintigraphy
We acquired SPECT images at 30 min (early) and
at 4 h (delayed) after 123I-BMIPP (111MBq; Nihon
Medi-physics Co. Ltd., Tokyo, Japan) was injected
into the left antecubital vein to determine uptake.
The heart-to-mediastinum (H/M) ratio and the
washout rate (WR) were calculated from the planar
images. 
Anterior and lateral planar images were
acquired for 90 s before the SPECT study using
a gamma camera with a low-energy, general-
purpose collimator and a 256 × 256 matrix. We
acquired BMIPP images using a double-head
gamma camera (E.CAM duet, Toshiba Medical,
Tokyo, Japan) with a low-energy, general-purpose
collimator. Two detectors (2 × 180°) acquired 60
views for 19 s in 6° steps using a 64 × 64 matrix.
The energy window of 123I was centred at 160 keV
±10%. Transaxial images were reconstructed after
filtered back projection using a Butterworth filter
(order, 8; cut-off frequency, 0.27 cycles/cm).
Coronal slices were generated after reorienting
the axes. Standard electrocardiography gated
images were acquired over 64 steps in 19 s per
step in the step-acquisition mode in the R-R
interval and divided into 16 frames. Tracer uptake
was assessed by creating non-gated early images
from the sum of all gated images obtained in the
standard-acquisition mode.
All patients underwent scintigraphy 1 day before,
and again at 1 month after successful PCI. Coronary
angiography confirmed successful revascularization
at 3 months after PCI. The controls were also
assessed by scintigraphy.
Data analysis
Regions of interest (ROIs) were drawn over the
entire heart and upper mediastinum in the planar
images. The H/M ratio and global WR of 123I-BMIPP
were calculated based on the ROIs as follows: 
H/M = mean pixel count of cardiac ROI/mean
pixel count of mediastinal ROI; WR (%) = [(mean
early cardiac pixel count – mean delayed cardiac
pixel count)/mean early cardiac pixel count] × 100. 430 Arch Med Sci 3, June / 2011
Background and time decay were not corrected
to calculate the WR.
After a SPECT image was acquired and recon  -
structed, the left ventricular (LV) myocardium was
divided into 17 segments as recommended [12] and
then segment defects were scored as 0 (normal), 
1 (slightly reduced), 2 (mildly reduced), 3 (severely
reduced) and 4 (absent). The total defect score
(TDS) was defined as the sum of the segment
defect scores for each participant.
Ventricular edges and LV ejection fraction (LVEF),
LV end-diastolic volume (LVEDV) and LV end-systolic
volume (LVESV) were evaluated using quantitative
gated SPECT (QGS) software (Cedars-Sinai Medical
Center, Los Angeles, CA). The algorithm for
determining edges and calculating volume has
been described previously [13].
Ethics
The study protocol consisting of blood tests,
echocardiography, an exercise stress test, cardiac
catheterization, and a BMIPP radionuclide study
proceeded in accordance with the ethical principles
established in the Declaration of Helsinki. The
Human Investigation Committee of St. Marianna
University School of Medicine approved the study
protocol. The nature and purpose of the study and
involved risks were fully explained to all participants
who then provided written informed consent to
participate in all procedures associated with the
study before enrolment.
Statistical analysis
Results are expressed as means ± SD. The
significance of differences between the patients
with AP and the controls was analysed using an
unpaired t test. Differences before and after PCI
were analysed and the parameters of early and
delayed data in the same individual were compared
using a paired t test. A p value of < 0.05 was
considered statistically significant.
Results
Baseline characteristics
Table I shows the clinical characteristics of the
patients and controls. Age did not significantly differ
between the two groups (p > 0.2). The QGS data
uncovered no significant differences in LVEF
between patients before PCI and the controls (64.0
±13.7% vs. 70.4 ±10.5%, p > 0.2). The plasma BNP
concentration significantly differed between patients
with AP before PCI and the controls (55.1 ±21.0 pg/ml
vs. 26.5 ±15.4 pg/ml, p = 0.0018). All patients were
medicated with 100 mg of aspirin per day. Seven of
the patients and 3 controls were prescribed with
statins to reduce serum cholesterol concentrations. 
BMIPP scintigraphic study
SPECT images
The early and delayed TDSs in the controls were
1.2 ±0.5 and 2.1 ±0.5, respectively. Successful PCI
decreased the early TDS from 5.5 ±1.8 to 2.8 ±1.1 in
the patients (p < 0.001). Moreover, the delayed TDS
in the patients significantly decreased from 7.5 ±1.7
to 5.3 ±1.8 after PCI (p < 0.001).
The early TDSs were significantly higher before
and after PCI in the patients than in the controls
(before PCI, p < 0.001; after PCI, p = 0.004). The
delayed TDSs in the patients before and after PCI
were also higher than delayed TDSs in the controls
(p < 0.001 for both groups). 
There were no significant differences in LVEDV
(controls 44.6 ±14.5 ml; before PCI 51.4 ±12.3 ml; after
PCI 53.0 ±16.0 ml), LVESV (controls 14.3 ±8.6 ml;
before PCI 19.3 ±9.2 ml; after PCI 21.5 ±12.1 ml) or
LVEF (controls 70.4 ±10.5%; before PCI 64.0 ±13.7%;
after PCI 62.3 ±13.4%) between the controls and
patients before and after PCI (all p > 0.2; Figure 1 top). 
Planar images
The early and delayed H/M ratios did not
significantly differ between the patients before PCI
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AP Control
Patients No. 12 10
Age [years] 67.4 ±11.6 70.0 ±9.5
Male/female 9/4 5/6
Culprit 
LAD (cases) 8
LCX (cases) 2
RCA (cases) 2
CCS class 2.1 ±0.7
LVEF by QGS (%) 64.0 ±13.7 70.4 ±10.5
BNP [pg/ml] 55.1 ±21.0 26.5 ±15.4
Medications
Anti-platelet 12
ACE-I 1
ARB 2
β-blockade 4
Ca-blockade 3
Nitroglycerin 5
Statin 7 3
Table I. Subjects' background
AP – angina pectoris, LAD – left anterior descending, LCX – left
circumflex, RCA – right coronary artery, CCS – Canadian Cardiovascular
Society, LVEF – left ventricular ejection fraction, QGS – quantitive gated
SPECT, BNP – brain natriuretic peptide, ACE-I – angiotensin converting
enzyme inhibitor, ARB – angiotensin receptor blockade, Ca – calcium.
Some values are expressed as mean ± SDArch Med Sci 3, June / 2011 431
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and the controls (early 2.70 ±0.36 vs. 2.73 ±0.57;
delayed 2.26 ±0.33 vs. 2.40 ±0.43, all p > 0.2) and
remained unchanged after PCI compared with
those before PCI (early 2.72 ±0.27; delayed 2.23
±0.22, all p > 0.2). The global WR before PCI was
significantly higher in the patients than in the
controls (36.7 ±9.3% vs. 28.1 ±8.2%, p = 0.025),
whereas the WR after PCI did not significantly differ
between them (34.3 ±7.8% vs. 28.1 ±8.2%, p = 0.10;
Figure 1 bottom). 
Discussion
The present study discovered that the global WR
of BMIPP in the myocardium was accelerated in
patients with stable AP before PCI but did not differ
from control values after successful PCI.
The significance of BMIPP myocardial WR remains
a matter of debate. We previously showed that an
accelerated BMIPP WR indicated myocardial disease
[8]. The WR of BMIPP could not fully discriminate
full from partial BMIPP β-oxidation in the
myocardium, although one study demonstrated that
BMIPP washout and back-diffusion significantly
increase in patients with heart failure [14]. The
present study included only patients with stable AP,
and the WR of BMIPP might be accelerated even
more in patients with unstable AP . The β-methyl
side-branch of BMIPP prolongs BMIPP accumulation
in the myocardium through impeding β-oxidation
[1]. Actual myocardial fatty acid disorders might have
been reflected more accurately by delayed than by
early uptake in the present study, because of the
slow myocardial clearance of BMIPP . Mitochondrial
fatty acid metabolism might be inhibited in patients
with AP and myocardial ischaemia. Thus, the delayed
H/M ratios did not significantly differ between
patients with AP after PCI and the controls. Our
previous study demon  strated lower BMIPP uptake
in patients with heart failure than with AP [8]. This
is attributed to a myocardial energy deficiency in the
failing heart [9]. 
Stress tests can be restricted in elderly patients
with orthopaedic disease and in those with
bronchial asthma. The administration of contrast
media can induce nephropathy in patients with
chronic kidney disease which is often fatal [15, 16].
However, myocardial ischaemia can be identified
by BMIPP image acquisition even in planar images,
without the need for stress tests. The non-invasive
aspect of BMIPP imaging is important for evaluating
the effect of catheter revascularization in patients
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Figure 1. Quantitative gated single photon emission computed tomography findings. Top: Parameters in controls,
before and after PCI*. There were no significant differences in LVEDV (44.6 ±14.5 ml, 51.4 ±12.3 ml and 53.0 ±16.0 ml,
respectively), LVESV (14.3 ±8.6 ml, 19.3 ±9.2 ml and 21.5 ±12.1 ml, respectively) or LVEF (70.4 ±10.5%, 64.0 ±13.7%, 62.3
±13.4%, respectively). Bottom: Planar image shows no significant differences in early or delayed H/M ratios between
patients with AP before PCI and controls (early 2.70 ±0.36 vs. 2.73 ±0.57; delayed 2.26 ±0.33 vs. 2.40 ±0.43, all 
p > 0.2). Early and delayed H/M ratios after PCI remained unchanged compared with those before PCI (early 2.72 ±0.27;
delayed 2.23 ±0.22, all p > 0.2). Global WR before PCI was significantly higher in patients than in controls (36.7 ±9.3%
vs. 28.1 ±8.2%, p = 0.025). However, WR after PCI did not significantly differ between the AP patients and the controls
(34.3 ±7.8% vs. 28.1 ±8.2%, p = 0.10)
*All abbreviations are explained in the text of the manuscript
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with various cardiac diseases. This method would
allow further clinical assessments in patients with
various myocardial diseases.
The study population was small and thus further
studies on a larger population are required. The
regional WR of 123I-BMIPP should also be evaluated.
Although the prognostic value of the H/M ratios
and WR of 123I-BMIPP in patients with cardiac
disease remains unknown, this question should be
resolved to define how 123I-BMIPP can be optimally
applied as a prognostic indicator.
In conclusion, the present findings suggest that
the 123I-BMIPP WR obtained from planar images
enhances the likelihood of myocardial ischaemia.
Planar BMIPP images are still useful to determine
the outcomes of PCI. Further investigations are
needed to reach significant conclusions regarding
measurements of delayed H/M ratios in patients
with ischaemic heart disease.
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